(NU/1433-27) iFAST: The Provision of Business Consultancy to Assist Commercialisation of University Research.

Tender description

The emergence of bacteria that are resistant to antibiotics is a growing public health problem. In 2015, there were nearly 700,0000 antimicrobial resistance (AMR) infections in the EU, accounting for 33,000 deaths and 900,000 disability-adjusted life years (DALYs) . In fact the impact of AMR is similar to the combined burden of influenza, tuberculosis, and HIV, and the global increases in healthcare costs is forecast to range from $300 billion to more than $1 trillion per year by 2050. We have developed a breakthrough technology that delivers an antibiotic resistance test result in 1 hour. The technique rapidly measures phenotypic changes in bacteria after exposure to antibiotics. The objective is for the Executive (CEO Desig) to jointly work in a team with all above named individuals to bring the opportunity towards and ultimately achieve launch of a new spinout company. Lot 1: Newcastle, Sunderland, Northumbria, Durham, Teesside universities together with the University of Bath on behalf of the SETsquared Partnership (the Enterprise collaboration of the Universities of Bath, Bristol, Exeter, Southampton and Surrey) and any other HE Institution that wishes to join this DPS, as detailed in the Office for Students Register, https://www.officeforstudents.org.uk/advice-and-guidance/the-register/the-ofs-register/ will engage suitably qualified and experienced executives through the DPS as and when required over the DPS period. The specific requirements will be detailed in each individual further competition. The typical brief of an executive will be to: (a) Produce a viable business plan; (b) Obtain university approval for the venture; (c) Act for the company in the spin-out legal process and address all company formation matters; (d) Provide to the appropriate university all matters necessary for Research England and ESIF reporting requirements; (e) Secure (venture capital and/or other) funding in accordance with the business plan. This will be a cyclical process throughout the entire Research England, and potential ESIF project along with any additional funding streams.